NVRO - Nevro Corp.About Us
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
|
|
|
| Previous Close | $149.30 | Open | $148.89 |
| Volume | 2.2K | Market Cap | 5.094B |
| Yield | Last Dividend |
| Neurostimulation Devices Market Top Key ... | 10/27/20 |
| Summary of the Neurostimulation Devices Market Report Due to the various economic, technological, research & development and geographical aspects, the... | |
| Neurostimulation Devices Market Top Key ... | 10/27/20 |
| Summary of the Neurostimulation Devices Market Report Due to the various economic, technological, research & development and geographical aspects, the... | |
| Nevro (NYSE:NVRO) Raised to ???Positive?... | 10/24/20 |
| OTR Global upgraded shares of Nevro (NYSE:NVRO) to a positive rating in a research report report published on Wednesday morning, The Fly reports. Seve... | |
| The Daily Biotech Pulse: Gilead Gets Ful... | 10/23/20 |
| Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 22) Ami... | |
| Nevro to Report Third Quarter 2020 Finan... | 10/22/20 |
| REDWOOD CITY, Calif., Oct. 22, 2020 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative, evidence-b... | |
| Nevro (NYSE:NVRO) Upgraded to ???Positiv... | 10/22/20 |
| OTR Global upgraded shares of Nevro (NYSE:NVRO) to a positive rating in a research note released on Wednesday, The Fly reports. Several other equities... | |
| Neurosurgery Devices Market Expected to ... | 10/22/20 |
| Rise in incidences and prevalence of neurological conditions within the population and the advantage of neurosurgery over other conventional surgeries... | |
| Analysts Anticipate Nevro Corp. (NYSE:NV... | 10/20/20 |
| Equities research analysts predict that Nevro Corp. (NYSE:NVRO) will announce $103.56 million in sales for the current quarter, Zacks Investment Resea... | |
| Zacks: Brokerages Expect Nevro Corp. (NY... | 10/20/20 |
| Brokerages predict that Nevro Corp. (NYSE:NVRO) will report earnings per share (EPS) of ($0.58) for the current quarter, according to Zacks. Six analy... | |
| Liberty All-Star?? Growth Fund, Inc. Sep... | 10/15/20 |
| BOSTON , Oct. 15, 2020 /PRNewswire/ -- Below is the September 2020 Monthly Update for the Liberty All-Star Growth Fund, Inc. (NYSE: ASG ) Liberty All-... | |
| The Daily Biotech Pulse: Vertex Pulls Pl... | 10/15/20 |
| Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 14) 10X... | |
| The Daily Biotech Pulse: J&J Pauses Coro... | 10/13/20 |
| Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 12) 10X... | |
| Implantable Neurostimulators Market Size... | 10/13/20 |
| SAN FRANCISCO , Oct. 13, 2020 /PRNewswire/ -- The global implantable neurostimulators market size is anticipated to reach USD 11.0 billion by 2027, ex... | |
| Trending News-Global Electroceuticals Bi... | 10/06/20 |
| This report provides a detailed analysis of the Electroceuticals Bioelectric Medicine market, provides meaningful insights into the market, based on f... | |
| Global Transcutaneous Electrical Nerve S... | 10/06/20 |
| ???Global Transcutaneous Electrical Nerve Stimulators Market???Industry Trends and Forecast to 2026??? Comprehensive Research Report to Added In Datab... | |
| Nevro chief faces fraud claims | 10/05/20 |
| The ex-Australian head of a medical device company allegedly admitted he had made "a terrible mistake" when he was confronted with doctored invoices a... | |
| Neuromodulation Market Insights 2020 - S... | 10/01/20 |
| The Global Neuromodulation Market research report published by Reports and Data provides an in-depth analysis of the Neuromodulation industry and its ... | |
| The Daily Biotech Pulse: Moderna Inks 2 ... | 09/17/20 |
| Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 16) Ar... | |
| Nevro Initiates Plan for Manufacturing O... | 09/14/20 |
| REDWOOD CITY, Calif., Sept. 14, 2020 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative, evidence-... | |
| Nevro to Present at Upcoming Conferences | 09/01/20 |
| REDWOOD CITY, Calif., Sept. 1, 2020 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative, evidence-b... | |
| Liberty All-Star?? Growth Fund, Inc. Jul... | 08/14/20 |
| BOSTON , Aug. 14, 2020 /PRNewswire/ -- Below is the July 2020 Monthly Update for the Liberty All-Star Growth Fund, Inc. (NYSE: ASG ) Liberty All-Star ... | |
| Global Nerve Repair and Regeneration Mar... | 08/10/20 |
| DUBLIN--(BUSINESS WIRE)--The "Nerve Repair and Regeneration - Global Market Outlook (2018-2027)" report has been added to ResearchAndMarkets.com's off... | |
| Nevro to Present at Canaccord Genuity 40... | 08/07/20 |
| REDWOOD CITY, Calif., Aug. 7, 2020 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative, evidence-ba... | |
| Why Is Nevro (NVRO) Up 7.1% Since Last E... | 06/04/20 |
| Nevro (NVRO) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues. | |
| Nevro Appoints Finance Executive Roderic... | 06/04/20 |
| REDWOOD CITY, Calif., June 4, 2020 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative, evidence-ba... | |
| Nevro's (NVRO) Senza Omnia SCS System Ge... | 05/18/20 |
| Nevro (NVRO) received CE mark approval for the Senza Omnia SCS system, which is likely to boost its international presence. | |
| Nevro Announces CE Mark Approval of Senz... | 05/14/20 |
| REDWOOD CITY, Calif., May 14, 2020 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative, evidence-ba... | |
| Nevro (NVRO) Earnings and Revenues Beat ... | 05/07/20 |
| Nevro's (NVRO) domestic revenues improved on a year-over-year basis in Q1. | |
| Nevro To Participate in Upcoming May Con... | 05/04/20 |
| REDWOOD CITY, Calif., May 4, 2020 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative, evidence-bas... | |
| Will Nevro (NVRO) Report Negative Earnin... | 04/28/20 |
| Nevro (NVRO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the... | |
| Buy rating | 10/23/20 |
| Guggenheim initiates coverage with Buy rating and announces Price Target of $190.00 | |
| Strong Buy rating | 10/12/20 |
| SVB Leerink maintains Outperform rating and raises Price Target from $165.00 to $175.00 | |
| Strong Buy rating | 09/02/20 |
| Baird initiates coverage with Outperform rating and announces Price Target of $160.00 | |
| Strong Buy rating | 08/06/20 |
| SVB Leerink maintains Outperform rating and raises Price Target from $140.00 to $165.00 | |
| Buy rating | 08/06/20 |
| Citigroup maintains Buy rating and raises Price Target from $137.00 to $160.00 | |
| Strong Buy rating | 08/06/20 |
| Morgan Stanley maintains Overweight rating and raises Price Target from $145.00 to $150.00 | |
| Buy rating | 08/06/20 |
| Canaccord Genuity maintains Buy rating and raises Price Target from $116.00 to $153.00 | |
| Strong Buy rating | 08/06/20 |
| Wells Fargo maintains Overweight rating and raises Price Target from $141.00 to $153.00 | |
| Date | 2020-08-05 (AMC) | Est. (EPS/Rev.) | ($1.62)/ 37.85M |
| Actual (EPS/Rev.) | $-1.21/ $56.39 M | EPS (TTM) | 0 |
| Total Revenue | $1.3B | Total Liabilities | $2.1B |
| Cost of Revenue | $2.5B | Total cash flow | $3.2 |
| Total Assets | $29.98B |
| % Insider | 12.52% | % Institutional | 76.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Service Name | Trader | % Success | |
|---|---|---|---|
| Potential Trading Ideas | Potential Trading | 59.00 % | Follow |
| Optioneering-W | Sam Allen | 36.00 % | Follow |
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
We are not a registered investment advisor. All investments involve risk, individual's trading does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. References to specific securities should not be construed as a recommendation to buy or sell that security only mentioned for informational purposes.
